Hikal posts Q1 FY 24 consolidated PAT at Rs. 6.92 Cr
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Reiterates India’s commitment to the BRICS TB Research Network Initiative
Qualifyze specializes in Good Practice audits (GxP) audits and covers a wide range of areas, including excipients, starting materials, packaging, sustainability
KIMS has reported total income of Rs. 609.14 crores during the period ended June 30, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Gland Pharma has reported total income of Rs. 1246.23 crores during the period ended June 30, 2023
Pharma in Korea receives a 7% increase in ‘growth potential’ category according to the CPHI Annual Survey findings
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Fortis Healthcare has reported total income of Rs. 1665.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 310.07 crores during the period ended June 30, 2023
The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023
The company has posted net profit of Rs. 463.88 crores for the period ended June 30, 2023
The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The primary purpose of this collaboration is to bring the optimized protein into the Indian market
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023
Medica Superspecialty Hospital becomes the first private hospital in Eastern India to collaborate with UNICEF for breastfeeding workshop
Qualicaps is the third largest producer of hard capsules for oral dosage solutions
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
Subscribe To Our Newsletter & Stay Updated